Beta carotene: The controversy continues

Alternative Medicine Review

Volumn 5, Issue 6, 2000, Pages 530-545

  Patrick, L ^a  

^a Private Practice   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; CAROTENOID; LYCOPENE; XANTHOPHYLL;

CANCER RISK; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CIS ISOMER; CLINICAL TRIAL; DRUG ABSORPTION; DRUG ACTIVITY; DRUG STORAGE; FAT INTAKE; HUMAN; LUNG CANCER; NONHUMAN; REVIEW; SMOKING; STOMACH PH; TRANS ISOMER;

ABSORPTION; BETA CAROTENE; DRUG INTERACTIONS; HUMANS; ISOMERISM; NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034487531     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Safety evaluation of synthetic beta-carotene
2. Carotenoids: 1. Metabolism and physiology
3. Procarcinogenic and anticarcinogenic effects of beta-carotene
4. Prooxidant actions of carotenoids in biologic systems
5. Beta-carotene and aryl hydrocarbon hydroxylase in the rat: An effect of beta-carotene independent of vitamin A activity
6. Beta-carotene and risk of coronary heart disease. A review of observational and intervention studies
7. Epidemiological evidence for beta-carotene and cancer prevention
8. Nutrition and lung cancer
9. Modulation of genotoxic and related effects by carotenoids and vitamin A in experimental models: Mechanistic issues
10. Absorption, metabolism, and transport of carotenoids
11. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans
12. Normal serum response to oral beta-carotene in humans
13. Bioavailability and bioconversion of carotenoids
14. Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators
15. Gastric acidity influences the blood response to a beta-carotene dose in humans
16. Sucrose polyester and plasma carotenoid concentrations in healthy subjects
17. Absorption and transport of carotenoids
18. Plasma beta-carotene response in humans after meals supplemented with dietary pectin
19. Bioavailability of beta-carotene in humans
20. Carotene balances in boys in Ruanda where vitamin A deficiency is prevalent
21. Dietary factors that affect the bioavailability of carotenoids
22. Effect of dietary protein on the enzyme from rat and human intestine which converts beta-carotene to retinal
23. Studies on the intestinal absorption of radioactive beta-carotene and vitamin A in man. Conversion of beta-carotene into vitamin A
24. Vitamin A metabolism and requirements in the human studied with the use of labeled retinol
25. Distribution of orally administered beta-carotene among lipoproteins in healthy men
26. The transport of vitamin A and carotenoids in human plasma
27. The toxicity of beta-carotene
28. Plasma carotenoids in normal men after a single ingestion of vegetables or purified beta-carotene
29. Differences in plasma beta-carotene (P-BC) maintained despite similar dietary beta-carotene
30. Cis-trans isomers of lycopene and beta-carotene in human serum and tissues
31. Correlation between carotenoid concentrations in serum and normal breast adipose tissue of women with benign breast tumor or breast cancer
32. Carotenoid interactions
33. Effects of supplemental beta-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the ATBC study
34. Carotenoid and tocopherol concentrations in plasma, peripheral blood mononuclear cells, and red blood cells after long-term beta-carotene supplementation in men
35. Effect of 4 years of oral supplementation with beta-carotene on serum concentrations of retinol, tocopherol, and five carotenoids
36. Changes in serum carotenoids in subjects with colorectal adenomas after 24 months of beta-carotene supplementation
37. Effect of supplemental beta-carotene on plasma concentrations of carotenoids, retinol, and alpha-tocopherol in humans
38. Effect of lutein on beta-carotene absorption and cleavage
39. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses
40. HPLC separation of cis-trans carotene isomers in fresh and processed fruits and vegetables
41. Structural and geometrical isomers of carotenoids in human plasma
42. Biosynthesis of 9-cis-retinoic acid from 9-cis-beta-carotene in human intestinal mucosa in vitro
43. Observations on the effects of ingesting cis- and trans-beta-carotene isomers on human serum concentrations
44. Enzymatic formation of 9-cis, 13-cis, and all-trans retinals from isomers of beta-carotene
45. Retinoids in chemoprevention and differentiation therapy
46. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen
47. Chemoprevention of mammary carcinogenesis in the rat: Combined use of raloxifene and 9-cis-retinoic acid
48. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells
49. Biosynthesis of 9-cis-retinoic acid from 9-cis-beta-carotene in human intestinal mucosa in vitro
50. Evidence of cis-trans isomerization of 9-cis-beta-carotene during absorption in humans
51. Antioxidant activity of 9-cis compared to all-trans beta-carotene in vitro
52. In vivo antiperoxidative effect of 9-cis beta-carotene compared with that of the all-trans isomer
53. All-trans beta-carotene preferentially accumulates in human chylomicrons and very low density lipoproteins compared with the 9-cis isomer
54. Discrimination in absorption or transport of beta-carotene isomers after oral supplementation with either all-trans or 9-cis-beta-carotene
55. Serum response of all-trans and 9-cis isomers of beta-carotene in humans
56. 9-cis beta-carotene in human plasma and blood cells after ingestion of beta-carotene
57. Beta-carotene serum levels in patients with erythropoietic protoporphyria on treatment with the synthetic all-trans isomer or a natural isomeric mixture of beta-carotene
58. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: Effects of baseline characteristics and study compliance
59. The Beta-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestos-exposed workers
60. Effects of 12 years of beta-carotene supplementation on cancer incidence in the Physician's Health Study (PHS)
61. Nutritional intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease specific mortality in the general population
62. The involvement of free radicals in chemical carcinogenesis
63. Prooxidant actions of carotenoids in biologic systems
64. The effect of dietary vitamin E and beta-carotene on oxidation processes in rat testis
65. Dietary antioxidants and cigarette smoke-induced biomolecular damage: A complex interaction
66. Oxidation of tocopherols and carotenoids in human plasma by gas-phase cigarette smoke
67. Peroxyl radical scavenging of beta-carotene in lipid bilayers: Effect of oxygen partial pressure
68. Beta-carotene and alpha-tocopherol are synergistic antioxidants
69. Antioxidant action of carotenoids in vitro and in vivo and protection against oxidation of human low density lipoproteins
70. Susceptibility of human LDL to oxidative modifications: Effects of variations in beta-carotene concentration and oxygen tension
71. Reactions of β-carotene with cigarette smoke oxidants. Identification of carotenoid oxidation products and evaluation of the prooxidant/antioxidant effect
72. Induction of a 70 kD protein associated with the selective cytotoxicity of beta-carotene in human epidermal carcinoma
73. Thermal interconversion among 15-cis, 13-cis, and all-trans-beta-carotene: Kinetics, Arrheius parameters, thermochemistry, and potential relevance to anticarcinogenicity of all-trans-beta-carotene